Provide Rx Health Group is the trusted innovator of the Utah Public Employee Health Plan’s Prescription Tourism Program. As part of the Provide Rx Health providers network, partners gain a compliant path to affordable access for their members.
Since 2018, our initiatives have saved the state of Utah’s government employee health plan members hundreds of thousands of dollars in prescription costs. The Provide Rx Health program offers its partners substantially lower prescription medication prices.
Partnerig with Provide RX Health can reduce member prescription medication costs by up to 70%, and our health plan partners have recognized the positive impact on their members well-being and savings.
When you partner with Provide Rx Healthcare, we guide your subscribers trough the prescription ordering process, and assign each healthcare member a bilingual Case Manager. Each member’s order is processed safely, easily, and reliably, by our professional customer service representatives and fulfillment pharmacies.
Under current law, certain drugs from Canada can be imported, solely if the Secretary of Health and Human Services (HHS) certifies that importation does not pose a threat to the American public’s health and safety. In September 2020, the FDA released final guidelines for safe drug importation from Canada and other countries.
The current US political position has opened the door for states to implement prescription drug importation initiatives and mandates the FDA to work with states to support prescription drug importation from Canada.
Americans pay more for their prescription medications than in most developed countries. According to one analysis, commonly prescribed brand-nameimported prescription medication prices were found to be 48% lower than of those in the United States on average.
Any drug to be imported into the US must meet FDA standards established by the Food and Drug Cosmetic (FD&C) Act of 1938.
Now, legally imported prescribed medications are limited to those that are manufactured in foreign FDA-inspected facilities and are subject of an FDA-approved drug application, intended for use by U.S. consumers, and imported into the U.S. by the drug manufacturer.
Congress enacted the Medicine Equity and Drug Safety (MEDS) Act, which added Section 804 to the FD&C Act, to allow pharmacists and wholesalers to import prescription medications from industrialized countries, including Canada, subjected tolimitations, safeguards, and a stipulation that the HHS Secretary demonstratesthe program poses no additional risk to the public’s health and safety, and results in a significant reduction in the cost of covered products to the American consumer.
Importation of prescription drugs under conditions established by the MEDS Act, and also by the MMA, then allowed wholesalers and pharmacists to obtain FDA-approved drugs at reduced prices viapurchase from foreign sellers and pass these savings on to the American public.
In 2020, the US Government issued a final rule and final FDA guidance for the importation of prescription medication. Under this ruling, states, territories, and Indian tribes, and under some conditions, pharmacists and wholesalers are authorized to enact time-limited importation programs, known as Section 804 Implementation Programs or SIPs, for Canada.
The final FDA guidance outlines guidelines for manufacturers to legally import and market FDA-approved drugs that have been manufactured in other countries, in the U.S.with the intent of marketing in the US. However, they must be authorized for sale in a foreign country.
By implementing this rule, a pharmaceutical manufacturer can obtain a National Drug Code (NDC) for drugs the intent to import to the U.S. In the recent past, numerous manufacturers have expressed to the Administration their goal to offer reduced cost options but were not effective because they were bound by contracts with extraneous supply chain parties. This situation now highlights an opportunity for manufacturers to offer reduced cost options for these medications.
In most circumstances, it isn’t legal for individuals to import FDA-approved drugs from other countries for personal use. However, based on changes enacted by the MMA, personal importation of prescription drugs that have not been approved by the FDA for use in the U.S. is restricted and has an individual case study approach.
The FDA has published guidance that outlines circumstances where importation of non-FDA approved drugs for personal use may be allowed.
Personal importation is normally permitted if the treatment is for a life-threatening condition, and where there is no effective alternatives available in the U.S., and there is no commercialization of the drug for use by United States residents.
Generally, a 90 day supply of prescribed medications is allowed, and individuals must affirm that the drug is for personal use, and provide valid physician information, and prescriptions for their request.
Provide Rx Health was created with a simple focus on helping people and healthcare providers access tremendous savings through imported pharmaceuticals, and medical tourism programs.
Interested in our Prescription Tourism Program?
Send us your valid prescription through our secure HIPAA-compliant system. Our team will coordinate your travel to Tijuana and connect you with trusted pharmacies to purchase your medications directly.
